跳转至内容
Merck
CN

SRP6039

Pro-MMP-13 human

recombinant, expressed in Sf9 cells, ≥95% (SDS-PAGE)

别名:

MMP recombinant, MMP13, Matrix metalloproteinase-13, procollagenase 3

登录 查看组织和合同定价。

选择尺寸


关于此项目

化学文摘社编号:
NACRES:
NA.32
UNSPSC Code:
12352202
Form:
liquid
Assay:
≥95% (SDS-PAGE)
Biological source:
human
Recombinant:
expressed in Sf9 cells
Mol wt:
53.820 kDa
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

human

recombinant

expressed in Sf9 cells

assay

≥95% (SDS-PAGE)

form

liquid

mol wt

53.820 kDa

packaging

pkg of 10 μg

concentration

~100 μg/mL

impurities

Endotoxin, tested

NCBI accession no.

shipped in

wet ice

storage temp.

−70°C

Gene Information

human ... MMP13(4322)

General description

MMP13 (matrix metalloproteinase13) was first identified in 1994 in human breast cancer. It is produced as an inactive proenzyme, and is activated by the cleavage of its N-terminal region. MMPs constitute a single protein superfamily, which are further classified as collagenases, gelatinases, and stromelysins. Humans contain nine MMPs, and MMP13 is a member of the collagenases subfamily, and is also known as collagenase 3. MMP13 gene is localized to the human chromosome location 11q14.3–23.2, which houses the nine MMP genes.

Biochem/physiol Actions

MMP13 (matrix metalloproteinase13) functions against different types of ECM (extracellular matrix) components. It gets activated by and activates multiple MMPs, and hence, has a central role in the MMP cascade. This protein is frequently expressed in colorectal cancer (CRC), and this expression is linked with poor survival in CRC. MMP13 expression is absent in normal breast tissue, but is present in breast carcinoma suggesting its role in tumorigenesis. The expression of this protein can serve as a marker for tumor invasiveness, as its expression is induced during metastasis of multiple types of cancers, including squamous cell carcinomas of the head and neck, and this expression is usually linked to poor prognosis. Missense mutation in this gene results in the autosomal dominant disorder called Missouri type of human spondyloepimetaphyseal dysplasia (SEMDMO), which is characterized by abnormal growth and modeling of vertebrae and long bones.

Physical form

In 50 mM Tris-HCl, pH 7; 250 mM NaCl; 5 mM CaCl2; 1 mM ZnCl2

hcodes

Hazard Classifications

Aquatic Chronic 3

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yiwen You et al.
Cancer science, 106(12), 1669-1677 (2015-09-13)
Nasopharyngeal cancer (NPC) is an endemic type of head and neck cancer with a high rate of cervical lymph node metastasis. Metastasis is the major cause of death in NPC patients. Increasing evidence indicates that exosomes play a pivotal role
A Matrix Metalloproteinase Gene Expressed in Human T Lymphocytes is identical with Collagenase 3 from Breast Carcinomas.
Willmroth, Frank, et al.
Immunobiol., 198, 375-384 (1998)
M F Leeman et al.
Journal of clinical pathology, 55(10), 758-762 (2002-10-02)
The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes collectively capable of degrading all extracellular matrix components, in particular fibrillar collagen. The importance of this group of proteins in the processes of tumour invasion and metastasis is now widely
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.
Freije JM, et al.
The Journal of Biological Chemistry, 269(24), 16766-16773 (1994)
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer.
Leeman MF, et al.
Journal of Clinical Pathology, 55(10), 758-762 (2002)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持